Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-05-10
1991-08-13
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530330, A61K 3702, C07K 706
Patent
active
050396625
ABSTRACT:
The invention discloses an acylated pentapeptide that inhibits metastasis activity of malignant cells.
REFERENCES:
L. Furcht et al., "Peptide Fragments of Fibronectin and Laminin: Role in Cell Adhesion and Inhibition of Experimental Tumor Metastasis", Development Oncology 41:43 (1986).
L. T. Furcht et al., "Peptide Fragments of Laminin and Fibronectin Promote Migration (Haptotaxis and Chemotaxis) of Metastatic Cells", CIBA Foundation Symposium 108:130 (1984).
J. Graf et al., "Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding", Cell 48:989 (1987).
Yukihide Iwamoto et al., "YIGSR, A Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation", Science 238, 1132-1134 (1987).
Makoto Sasaki et al., "Sequence of the cDNA Encoding the Laminin B1 Chain Reveals a Multidomain Protein Containing Cysteine-Rich Repeats", Proc. Natl. Acad. Sci., USA 84:935 (1987).
Jeannette Graf et al., "A Pentapeptide from the Laminin B1 Chain Mediates Cell Adhesion and Binds the 67000 Laminin Receptor", Biochemistry 26:6896 (1987).
Lee Lester L.
Monsanto
LandOfFree
Peptide with anti-metastasis activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide with anti-metastasis activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide with anti-metastasis activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1527378